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Three-dimensional (3D) optical imaging techniques can expand our knowledge
about physiological and pathological processes that cannot be fully understood
with 2D approaches. Standard diagnostic tests frequently are not sufficient to un-
equivocally determine the presence of a pathological condition. Whole-organ op-
tical imaging requires tissue transparency, which can be achieved by using tissue
clearing procedures enabling deeper image acquisition and therefore making
possible the analysis of large-scale biological tissue samples. Here, we review
currently available clearing agents, methods, and their application in imaging of
physiological or pathological conditions in different animal and human organs.
We also compare different optical tissue clearingmethods discussing their advan-
tages and disadvantages and review the use of different 3D imaging techniques
for the visualization and image acquisition of cleared tissues. The use of optical
tissue clearing resources for large-scale biological tissues 3D imaging paves the
way for future applications in translational and clinical research.
INTRODUCTION
In the last few decades, huge advances have been made in non-invasive imaging techniques, including the
development of magnetic resonance imaging (MRI), positron emission transmission (PET), and computed
tomography (CT) (Azaripour et al., 2016). These technologies produce 3D images, which enable good visu-
alization of the anatomy and structure of human and animal tissues (Anzai et al., 2019). From a clinical point
of view, the resolution provided by these techniques is sufficient, in the sense that cellular accuracy is not
required for diagnosis or treatment. However, in some studies, it is necessary to acquire images at subcel-
lular resolution while maintaining the 3D structure. A prime example of this need is the study of neuronal
circuitry (Sato et al., 2019). A thorough analysis of the neuronal connections in the brain requires 3D images
at cellular or even subcellular resolution. The aforementioned clinical imaging modalities enable non-inva-
sive 3D imaging but do not reach cellular resolution, necessary to provide information about the tissue cy-
toarchitecture. Also, in most cases it lacks sufficient specificity as to identify different cell populations and
therefore cannot be used for this purpose, at least for the time being.
At the other end of the spectrum, histological techniques provide high-resolution cellular and subcellular
2D images but require the tissue under study to be cut into thin slices. However, when the tissue is cut into
sections, the 3D structure of the organ becomes difficult to reconstruct. Although some image processing
programs are designed to generate histological 3D reconstructions such as FIJI (Schindelin et al., 2012),
MATLAB (Krı́zek et al., 2016), Imaris (Haass-Koffler et al., 2012), and Amira (Hikspoors et al., 2017), image
stacking is rather laborious, leads to anisotropic resolution, andmay not be reliable if slices undergo defor-
mation. Consequently, it is difficult to achieve high-resolution 3D reconstructions even after correcting
stripes and illumination artifacts with preprocessing methods such as the "rolling ball" algorithm imple-
mented in MATLAB (Leischner et al., 2010) and the ‘‘N4’’-Algorithm implemented in 3DSlicer (Fedorov
et al., 2012).
Alternative optical imaging modalities, such as confocal microscopy, generate highly accurate 3D images
and are frequently used with fluorophore-stained samples (Willadsen et al., 2018). A confocal microscope is
similar to a normal fluorescence microscope in the sense that it illuminates the sample with light of a spe-
cific wavelength, which is absorbed by fluorophores that re-emit light of longer wavelengths. ConfocaliScience 21, 101432, August 21, 2020 ª 2020 The Authors.
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Figure 1. Schematic Showing the Fundamental Physics and Functioning of the Imaging and Spectroscopic Techniques Considered in This Review
The biological sample is represented by a central brown rectangle, the objective by a blue ellipsoid, the photodetectors by purple boxes, and the laser
emitters and detector by a black box. Blue: LSFM. Red: confocal microscopy. Green: Brillouin spectroscopy. Yellow: Multiphoton microscopy. Brown: SRS
microscopy. Brillouin and Raman graphs represent laser intensity versus frequency. Confocal and Raman microscopes may irradiate the sample from the
opposite direction too.
(A) Input from the different 3D imaging systems. Each color represents the laser beamproduced by the source of each imaging system. Discontinuous lines in
the color spectrum represent commonly used excitation wavelengths (nm) in LSFM, and continuous lines represent in the same color the peak wavelength of
the corresponding emission filters used. Raman microscope image was adapted from Stimulated Raman Scattering Microscopy (https://www.castl.uci.edu/
sites/default/files/Min%20SS%20presentation.pdf), Confocal microscope image was adapted from Zeiss microscopy (https://www.zeiss.com/microscopy/
int/products/confocal-microscopes/lsm-900-for-materials-non-contact-surface-topography-in-3d.html).
(B) Output of the 3D imaging systems. Each color represents the laser beam obtained from the sample. Below each imaging system, the physical mechanism
on which each one is based is graphically shown. Confocal, multiphoton, and LSFM microscopies are based on fluorescence, whereas Brillouin is based on




Reviewmicroscopes can create thin 3D images by detecting fluorescence light produced at the focal spot and
by moving the position of this spot. That is, instead of exciting the entire specimen evenly and detecting
fluorescence emitted from the whole sample, confocal microscopy excludes out-of-focus fluorescence
(Figures 1).
Nevertheless, optical imaging is hampered by reduced light penetration when a tissue or organ is not
transparent. The main causes leading to tissue opacity are refractive index (RI) mismatch between lipid
and aqueous media interfaces (Chung et al., 2013) and non-homogeneous distribution of scatterers (Ri-
chardson and Lichtman, 2015), mainly lipids, collagen fibers, and myofibrils. Light absorption is a minor
cause of tissue opacity in mammals, as very few chromophores can absorb electromagnetic waves in the
visible range; hence, light absorption can be almost disregarded in tissues that are not rich in heme groups
or melanin (Inyushin et al., 2019). It is important to notice that this is not the case of invertebrates or several
animal species, in which pigments such as ommochromes or pterins constitute a significant cause of opac-
ity, and for which particular depigmentation clearing protocols have been specifically developed, such as
DEpigmEntation-Plus-Clearing (DEEP-Clear) (Pende et al., 2020) or FlyClear (Pende et al., 2018), which can
also eliminate heme groups andmelanin. But in most studiedmammals whatsoever, lipids and RI mismatch
are the major factors that lead light to be scattered instead of traveling straight through the tissue, causing
blurring and opacity. Non-transparent tissues are therefore not suitable for the acquisition of high-resolu-
tion images (Kolesová et al., 2016). Thus, obtaining high-accuracy 3D images makes it necessary to turn tis-
sues or organs transparent using clearing agents. In some cases (e.g., benzyl alcohol/benzyl benzoate
[BABB]), the sample must be fixed and dehydrated (Dodt et al., 2007; Genina et al., 2010) before being
immersed in a clearing agent. Some clearing agents like CUBIC (clear, unobstructed brain image cocktails
and computational analysis) (Susaki et al., 2014) reduce lipid content. CUBIC also induces tissue swelling,
reducing the overall RI as predicted by the Lorentz-Lorenz equation and, therefore, facilitating RI matching
(Ueda et al., 2020). For a summary of the different steps that can be followed by most optical clearing
methods see Figure 2.
In general, clearing agents improve light penetration by eliminating lipids and natural pigments matching
the tissue refractive indices (RIs). Spatial distribution of different structures in tissue can serve to evaluate
the functional status of an organ, for example, in the case of the muscle (Yin et al., 2019).
Human tissues like placenta, myocardial tissue, and some others have been optically cleared successfully,
enabling a deeper comprehension of the 3D microanatomy and cytoarchitecture of the tissues and
bringing light for more accurate diagnosis and treatments. In the case of the placenta, it allowed a better
evaluation of the morphology and transport capacities of placental blood barriers (Carrillo et al., 2018),
whereas in the case of myocardial tissue it has been used to evaluate the organization of collagen in healthy
hearts and in heart failure tissue (Perbellini et al., 2017). Optical clearing has also been presented as a
powerful 3D histopathology tool for pancreatic lesions diagnosis (Hong et al., 2019), in order to detect
and visualize endocrine and exocrine pathologies and to evaluate the 3D architecture of neoplasia lesions
and adenocarcinomas (Matryba et al., 2019). In fact, cellular resolution is fundamental for early diagnosis, as
several diseases arise as a direct consequence of changes in cellular structure and behavior (Antonacci and
Braakman, 2016) even before they are fully noticed. Technological advances in the microscopy field have
allowed 3D imaging techniques to achieve such resolution.iScience 21, 101432, August 21, 2020 3
Figure 2. Workflow Summarizing the Different Possible Steps that an Optical Clearing Method Can Follow to Render a Whole Organ Transparent
The chosen pipeline will depend on the properties of the tissue that is going to be treated and on the specific goals desired. Each box represents a specific




ReviewTRANSPARENCY AND TISSUE CLEARING METHODS
Tissue opacity, which results from light absorption and scattering, prevents light from penetrating the sam-
ple and thus impairs excitation of fluorescent proteins, such as green fluorescence protein (GFP) or labeled
antibodies.
Comprehensive analyses of histological sections are limited by poor penetration of the antibodies and
laser light. Clearing protocols increase transparency and improve not only penetration of laser light but
also diffusion of antibodies into the sample (Nehrhoff et al., 2016), thus enabling the analysis of thick layers
of biological tissue.
Most available clearing agents are inspired organic solvents (Costantini et al., 2019), such as BABB or benzyl
alcohol/glycerol (Pires et al., 2016), which generally have fast clearing dynamics (Qi et al., 2019). However,
alcohols present in these organic solvents have been reported to quench and weaken the fluorescence
signal in organs (Dodt et al., 2007; Genina et al., 2010). New organic solvent-based methods such as
uDISCO (Pan et al., 2016), FDISCO (Qi et al., 2019), or sDISCO (Hahn et al., 2019), which are described in
further detail below, have been developed to overcome this issue and better preserve fluorescence. Table
1 summarizes themain characteristics of several clearing agents and how they affect the physical properties
of the tissue (Kim et al., 2018).
In contrast, other clearing agents such as ClearT and ClearT2 do not contain organic solvents (Cai et al.,
2019). It has been reported that ClearT2 does not disrupt the fluorescence signal and that ClearT clears or-
gans faster than BABB (Kuwajima et al., 2013). However, ClearT is incompatible with immunohistochemistry
and genetically encoded fluorescent proteins, such as GFP, and the clearing power of ClearT2 is not strong
enough. As an alternative, a new clearing method has been recently developed, called RTF, which is based
on ClearT2. It shows better clearing capacity while preserving compatibility with immunostaining and
endogenous fluorescence signals (Yu et al., 2018). CLARITY (clear lipid-exchanged acrylamide-hybridized
rigid imaging/immunostaining/in situ hybridization-compatible tissue-hydrogel) was also developed to
overcome fluorescence quenching of organic solvent-based clearing protocols and to better preserve tis-
sue structure at a subcellular level when performing in situ hybridization of the sample (Chung et al., 2013).
Combining CLARITY with ETC (electrophoretic tissue clearing) renders faster results by using charged mi-
celles for electrophoretic extraction of lipids (Chung et al., 2013). CLARITY uses SDS for this step owing to
its amphipaticity (Table 2), which makes it ideal for this kind of micelle-mediated lipid removal. However,
excessive heating can damage the sample, so PACT (Passive Clarity Technique) was developed to perform
passive clearing at a faster speed by facilitating the diffusion of SDS. This is achieved by reducing the den-
sity of the hydrogel and by excluding CLARITY’s bis-acrylamide cross-linker (Yang et al., 2014b). As an RI
matching solution, PACT can make use of RC-CD (PACT-RC) (Lloyd-Lewis et al., 2016), RIMS (Yang et al.,
2014b), or sRIMS (PACT-sRIMS), which uses Sorbitol to provide RIMS with clearing capacity (Treweek4 iScience 21, 101432, August 21, 2020
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ACT-PRESTO Hydrogel + SDS S Brain, Shrinkage Short Y N (Lee et al., 2016)
Adipo-clear Methanol, DCM, DBE, Triton X- O Adipose tissue No Short Y Y (Chi et al., 2018)
a-UDISCO Tert-butanol, BABB-D4 (benzyl
alcohol, benzyl benzoate,













Short (19 h) N.D. N (less than
uDISCO)
(Li et al., 2018)
BABB 33% Benzyl alcohol, 67% benzyl
benzoate
O Mouse embryo, brain,
tumor, kidney, human
aorta, lung
Shrinkage Short Y (before
clearing)
Y (Dodt et al., 2007)
(Genina et al., 2010)
BAG 55% Benzyl alcohol
45% Glycerol
O ? Shrinkage Short Y (before
clearing)
Y (Dodt et al., 2007)
(Genina et al., 2010)
BoneCLARITY 10% EDTA, 4% acrylamide, SDS,
RIMS
S Mouse femur, tibia,
and vertebral column
Swelling Very long (28 d) Y N (Greenbaum et al.,
2017)
Ce3D N-methyl acetamide, Histodenz,
1-thioglycerol, Triton X-







Short Y N (Li et al., 2017)
CLARITY SDS, acrylamide S Whole body, mouse
embryo, mouse heart,
brain, lung,
Shrinkage Very long Y N (Chung et al., 2013)
ClearT 100% Formamide A Mouse brain and
embryos
N Medium N Y (Kuwajima et al.,
2013)
ClearT2 Formamide and PEG A Liver N Medium Y N (Kuwajima et al.,
2013)
CRISTAL Ethanol, xylene, resin O Rat lung, brain, bone Not mentioned 5 d - 3 w Y Y (Kellner et al., 2016)
Table 1. Main Features of Clearing Reagents and Methods






























































Polyalcohols, triton, urea, sucrose,
nitriloethanol







Expansion Medium Y Y (Susaki and Ueda,
2016;
Susaki et al., 2014)
CUBIC1 CUBIC-L (10 wt %
N-butyldiethanolamine, 10 wt % Triton
X-100), CUBIC-P (5 wt %
1-methylimidazole, 10 wt %
N-butyldiethanolamine), 10 wt % Triton
X-100 CUBIC-R (5 wt % antipyrine,
30 wt % nicotinamide, optionally pH 8–9
adjusted by N-butyldiethanolamine), or
CUBIC-RA 5 wt % antipyrine, 30 wt %
N-methylnicotinamide, optionally pH
8–9 adjusted by N-butyldiethanolamine




Medium (5–9 d) Y N (Tainaka et al., 2018)
CUBIC2 CUBIC-L, CUBIC-P, CUBIC-B
(10 wt % EDTA, 15 wt % imidazole)
and CUBIC-R or CUBIC-RA
A Mouse leg, head,
spine, and whole body
N (for neutral
pH of CUBIC-R)
Long (12–21 d) Y N (Tainaka et al., 2018)
CUBIC3 CUBIC-HL (10 wt % 1,3-
bis(aminomethyl)cyclohexane, 10 wt %
sodium dodecylbenzene sulfonate, pH
12.0 adjusted by p-toluene sulfonic
acid), CUBIC-R




Medium (9–16 d) Y Y (Tainaka et al., 2018)
CUBIC4 CUBIC-L, CUBIC-R A Human brain N (for neutral
pH of CUBIC-R)
Medium (9–16 d) Y N (Tainaka et al., 2018)
CUBIC-cancer CUBIC-L, modified CUBIC-R (45 wt %
antipyrine and 30 wt % nicotinamide)
A Mouse liver, intestine,
pancreas, lung, brain





CUBIC clearing, 500 mM NaCl, HEPES






(11 d - 2.5 m)
Y N (Susaki et al., 2020)



























































CUBIC-X CUBIC-R1 (Polyalcohols, triton, urea),
CUBIC-X1 (20% imidazole), CUBIC-X2
(5% imidazole, 55% antipyrine cocktail)
A Mouse brain Swelling Long (2–3 w) Y N (Murakami et al.,
2018)
DBE Dibenzyl ether A Mouse brain N Short Y (before
clearing)
N (Becker et al., 2012)
DEEP-clear FlyClear solution 1 1 (N,N,N0,N’-
Tetrakis(2-hydroxyethyl)
ethylenediamine (THEED), Triton X-100,
urea), acetone, hydrogen peroxide and
solution 2 (meglumine diatrizoate)
A/O Bristle worm, squid,
Zebrafish, axolotl
N Short (less than 1
d)
Y N (Pende et al., 2020)
3DISCO iDISCO Tetrahydrofuran (THF)
Dichloromethane
Dibenzyl ether
O Most mouse organs Shrinkage Short Y N
Y (1–2 d
lifetime)
(Becker et al., 2012)
(Erturk et al., 2014)
ePACT Hydrogel + 10% SDS-PBS (pH 8) S Mouse brain Swelling Medium (1–2 w) Y N (Treweek et al., 2015)
Ethanol-ECi Ethyl-3-phenylprop-2-enoate O Kidney, heart Shrinkage Short (4 d) Y N (Klingberg et al.,
2017)
EyeCi ECi clearing + iDISCO immunolabeling O Mouse eye Shrinkage Short (1 w) Y ? (Decroix et al., 2015),
(Klingberg et al.,
2017)




Shrinkage Short (25 h–5 d) Y N (Masselink et al.,
2019)




Y N (Xu et al., 2017)
FASTClear THF, DBE O Human myocardium Shrinkage Very fast (45 min) Y N.D. (Perbellini et al., 2017)
FDISCO 4C/pH 9.0 THF and 4C DBE O Brain, kidney, muscle Shrinkage
(similar
to 3DISCO)
short (3–4 d) Y N (Qi et al., 2019)
FluoClearBABB 1-Propanol, tert-butanol O Mouse brain Shrinkage Medium (10 d) ? N (Schwarz et al., 2015)



























































Fly-clear Protease, acetone, Solution-1 (THEED,




N Medium (1 w) N.D. Y (Pende et al., 2018)
FRUIT Fructose and urea A Rabbit brain No shrinkage
for 30% FRUIT
Short (4 d) Y Y (Hou et al., 2015)
iDISCO+ Methanol, dichloromethane,
dibenzyl ether
O Mouse and rat brains N Very long (18 d) Y N.D. (Renier et al., 2014)
(Perin et al., 2019)
IsoScaleSQ 9.1 M urea, 22.5% (v/w) d-sorbitol,
200 mM sodium chloride, and 2% (v/w)
Triton X-100.
A Mouse brain N Very short
(30 min)
Y (thin slices) N (Sato et al., 2019)
LUCID TDE, glycerol, TBS, Tween 20 A Porcine
gastrointestinal
mucosa
N Short (5–7 d) Y N.D. (Hildebrand et al.,
2018)





Fast (2.5d) Y N (Zhu et al., 2020)
MASH DISCO with RIMS substituted by trans-
cinnamaldehyde, TDE, and
wintergreen oil
O Human cortex ND Medium Y ? (Hildebrand et al.,
2018)
MYOCLEAR Hydrogel (VA-044, A4P0), PTwH A Mice diaphragm
muscle
ND Long (17 d) Y N (Williams et al., 2019)
OPTIClear 20% w/v N-methylglucamine, 25% w/v
2,20-thiodiethanol, 32% w/v Iohexol





(Lai et al., 2018)
PACT Hydrogel + SDS
Optionally, sRIMS can be added
S Lung mouse embryo Shrinkage Medium Y N (Yang et al., 2014a)
PACT-deCAL 0.1 M EDTA in 1X PBS, 10% SDS-PBS,
hydrogel
S Tibia bone, vertebral
column
? Medium (1–2 w) Y ? (Treweek et al., 2015)
PARS Hydrogel + SDS S Whole mouse, human
tumor tissue
Shrinkage Medium Y N (Lai et al., 2018)



























































Passive CLARITY Nanoparticles S Mouse brain and spinal
cord
Shrinkage Very long Y N (Roberts et al., 2016)
PEGASOS Polyethylene glycol, 20% EDTA, 25%
N, N,N’, N’-Tetrakis (2-hydroxypropyl)
ethylenediamine, ammonium,
PEGMMA, BB






Medium (7–12 d) Y N (Jing et al., 2018)
ReagentF 2,20,200NItriloetahnol/Triethanolamide
formamide
A Neonatal mouse brain ? Fast (1 d) ? N (Jianru et al., 2015)
RTF Triethanolamine, formamide A Embryonic brain,
embryo.
N Short (h-1 d) Y Y (Yu et al., 2018)
Scale Urea, Triton X-, and glycerol A Mouse embryo, heart N Very long N.D. N (Hama et al., 2011)




N (Decroix et al., 2015)
(Richardson and
Lichtman, 2015)
ScaleS Sorbitol-based Scale A Mouse brain Slight
expansion
Medium (6 d) Y N (Hama et al., 2015)
(Wan et al., 2018)
ScaleSQ 9.1 M Urea, 22.5% (w/w) sorbitol A Mouse brain Strong
expansion
Short (h) Y Y (slightly) (Wan et al., 2018)
(Costa et al., 2019)
SCM CLARITY with a larger concentration
of VA-044
O Mouse heart Expansion Long (2–3 w) Y N (Matryba et al., 2019;
Richardson and
Lichtman, 2017)
sDISCO Hydroxytoluene, THF, BABB, DBE,
propyl gallate
O Mouse brain Shrinkage (30%
approx.)
Medium (1 w) N.D. N (Hahn et al., 2019)
SeeDB 80.2% with a 0.5% a-thioglycerol in
water
A Brain, mammary gland N Medium Y (brain) Y (Murakami et al.,
2018),
(Ke et al., 2016)
SeeDB2 Iohexol, saponin, and Tris-EDTA A Mouse brain N Short (2 d) Y N (Ke et al., 2016)
SOCAs Fructose, sucrose, PEG-400, propylene
glycol, thiazine
O Human skin N Short Y N (Guo et al., 2016)
SUT Urea, SDS, Triton X-, acrylamide,
and PBS
A Mouse, rat, and pigs’
heart
ND Depends on the
species (4–29 d)
Y N.D. (Wang et al., 2018)



























































SWITCH Glutaraldehyde, sodium sulfite, 1-
thioglycerol, SWITCH-off (PBS+0.5 mM
SDS), SWITCH-on (PBST)




Warping Medium (1–2 w) Y N.D. (Murray et al., 2015)
TDE 97% 2,20- Thiodiethanol in water A Brain Shrinkage Short Combined with
CLARITY
N (Costantini et al.,
2015)
UbasM Ub-1 (1,3-Dimethyl-2-imidazolidinone,
Meglumine, Triton X-, urea) and Ub-2






N Medium (7–12 d) Y N (Chen et al., 2017)
uDISCO Diphenyl ether, benzyl alcohol, benzyl
benzoate, vitamin E, tert-butanol
O Brain, liver, lung,
bone, whole rat
Shrinkage 4 d Y N (Pan et al., 2016)
vDISCO Tert-butanol 30%–100%,
dichloromethane
O Mouse brain, head,
and meninges






(Cai et al., 2019)
Table 1. Continued
PEG, polyethylene glycol; SDS, sodium dodecyl sulfate; O, organic solvent-based; A, aqueous-based; S, SDS; Y, yes; N, no; LN, lymphatic node; SOCAS, skin optical clearing agents; IHC, immunohistochem-



















































DCM 84.(Wei et al., 2019) CH2Cl2
DBE 198.2 C14H14O
Triton X- 250.3 C16H26O2
Benzyl alcohol 108.14 C6H5CH2OH








Table 2. Chemical Structure and Composition of Some of the Main Clearing Agents Currently Used
(Continued on next page)
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Ethyl cinnamate 176.2 C11H12O2
Table 2. Continued (Continued on next page)
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Reviewet al., 2015). PACT’s reagents can be perfused directly into the vasculature of the organ in larger samples
(D. et al., Yang et al., 2014a).
As may be understood from Table 1, there is no ‘‘ideal’’ clearing agent. Each one presents pros and cons,
and the researcher’s choice may depend on the particular type of biological sample or experiment. To
decide which clearing agent is the most appropriate for a specific analysis, we must take into consideration
aspects such as organ or tissue under study, type of fluorescence, the importance of tissue shrinkage, and
duration of the clearing. These aspects are individually addressed in the following paragraphs.
The specific organ or tissue under study is a relevant aspect since not all organs are cleared in the same way
by the various agents. Clearing agents act differently on different tissues owing to their intrinsic structure
and composition. For instance, it has been reported that CUBIC and PACT are the most appropriate
clearing agents for the lungs of mouse embryos (Hirashima and Adachi, 2015; Yang et al., 2014a). CUBIC




Reviewthe efficacy of the so-called CUBIC-1 and CUBIC-2 reagents, which can achieve delipidation and RI match-
ing in a cheap and rapid way (Susaki et al., 2014). Conversely, FocusClear (a proprietary reagent), which is an
RI matching solution, has been reported to be a quick clearing agent for visualization of the microvascula-
ture in thick tissue sections of mouse brains (Moy et al., 2013). The intensity of the fluorescence signal is also
relevant. For instance, organic solvents such as BABB (which quenches native fluorescence from endoge-
nous proteins) may be used if the organ under study has strong transgenic fluorescence emission because
the signal can still be detected or if antigen conjugated fluorophores are used (Sharpe et al., 2002). In
contrast, for tissues with a weak fluorescence signal, it would be more appropriate to choose a clearing
agent that better preserves fluorescence, such as Scale (Hama et al., 2011).
During tissue clearing, the organ is dehydrated and loses lipids and other components, thus reducing or-
gan size and potentially altering its structure. For experiments in which structure and cell morphology are
critical, it would be adequate to use 2,20-thiodiethanol (TDE), which is an RI matching solution that hardly
affects tissue structure (Costantini et al., 2015), or See Deep Brain (SeeDB) (Lloyd-Lewis et al., 2016), which
does not reduce sample volume and maintains cell morphology intact in mouse brains. This is an important
issue when studying neuronal circuits, in which the position and connections of neurons are analyzed in the
context of the whole organ. Robustness of the tissue must also be considered when choosing a specific
clearing protocol. For instance, large and mature organs are better cleared by SeeDB37ht rather than
SeeDB, and fragile tissues such as embryonic brains, by using SeeDBp. Both are SeeDB variants that differ
in the protocol length and duration of exposure to different fructose concentrations (Ke and Imai, 2014) (Ke
et al., 2013). The time required for the clearing agent to turn the tissue transparent (clearing time) varies
considerably depending on the organ and agent used. For instance, ClearT turns embryonic mouse brains
transparent much faster than Scale, which needs 2 weeks to achieve the transparency that ClearT achieves
in a single day (Kuwajima et al., 2013). This difference in clearing time can affect the duration and outcome
of the experiment because longer clearing times can increase transparency but also fluorescence quench-
ing. In any case, shorter clearing times are obviously preferable.
Although there is no perfect clearing agent, they are all generally expected to increase transparency, im-
age resolution, and depth of laser and antibody penetration. Although in most cases it is also desirable that
they minimally affect tissue integrity and organ size, changes in organ size might be beneficial in some
cases. For instance, organ swelling can potentially allow a better analysis of the whole tissue and may
also improve image resolution in applications such as expansion microscopy (Murakami et al., 2018). On
the other hand, tissue shrinkage can fit the sample into the working distance of the optical system and
therefore allow whole organ visualization. Even if some clearing agents quench fluorophores, they are ex-
pected to preserve the fluorescence signal when used properly. That is, as the tissue becomes more trans-
parent, light scattering is reduced, and the detection of the fluorescence signal is improved, thus enabling
visualization of fluorescence from deeper regions of the tissue provided.3D IMAGING TECHNIQUES: CONFOCAL, MULTIPHOTON, STIMULATED RAMAN
SCATTERING AND LIGHT SHEET FLUORESCENCE MICROSCOPY
Once an organ has been cleared, several techniques enable the acquisition of 3D images. The use of
confocal microscopy is limited to the analysis of thin sections, which may suffice for some experimental ap-
proaches but not for the generation of whole-organ 3D images. This is because confocal microscopes use
objectives of higher magnification, such as 20x or 40x, requiring a shorter working distance, whereas typi-
cally in light sheet fluorescence microscopy (LSFM), microscopes use low magnification objectives in the
2x–10x range, capable of imaging larger samples. In addition, the confocal microscope scans the sample
sequentially point by point, and thus exposes the sample continuously to laser light, which causes photo-
bleaching, whereas the LSFM microscope generates a light sheet that illuminates a single slice of the sam-
ple at a time, thus reducing photobleaching. Multiphoton microscopy also illuminates a single plane at a
time, as photon convergence for fluorescent stimulation only occurs at the focal plane (Figure 1A).
Although it provides a larger penetration depth than confocal microscopy and is less affected by sample
scattering (Costa et al., 2019), it is still unable to image large sample volumes at once. The LSFM setup, with
the sample inside a chamber and a long distance from the objective to the sample, makes it possible to
analyze larger tissue fragments.
However, similarly to confocal microscopy, LSFM requires fluorescent labeling, hence increasing clearing




Reviewcannot be fully avoided. To overcome this issue, label-free imaging techniques such as stimulated Raman
scattering (SRS) microscopy have been recently developed for 3D imaging with subcellular resolution (Wei
et al., 2019) (Figure 1B). SRSmicroscopy uses the resonant frequency of molecular bonds to detect different
cellular components. By irradiating a certain bond type with a pulse laser Ip and its corresponding Stoke’s
frequency Is if the frequency difference (Raman shift) matches the quantum height of the vibrational state of
the bond, a fraction of Ip becomes absorbed and reemitted by stimulated emission as Is. The intensity loss
of Ip is named SRL (stimulated Raman loss), and by detection of its magnitude for different Raman shifts at
each point of the sample, image reconstruction can be obtained (Freudiger et al., 2008). However, although
recent SRS-specific clearing techniques have been developed to improve the imaging depth of stimulated
Raman microscopy, SRS imaging potential regarding sample volume and depth still remains similar to that
of confocal (less than 1 mm3 and around 1 mm depth) (Wei et al., 2019). Therefore, LSFM is still the best
option for rapid, whole-organ 3D imaging.
In a typical custom-made multispectral light sheet microscope or LSFM, the sample is positioned by means
of three motorized stages that allow translation (X, Y, and Z) and a rotation motor (Zaber Technologies,
Canada). The imaging system consists of a scientific CMOS camera (Neo, Andor, Northern Ireland) with
2560 3 2160 active pixels and a physical detector size of 6.5 mm 3 6.5 mm and a tube lens placed after
the emission filter wheel.
The laser unit comprises five different excitation laser lines with powers ranging from 50 to 200 mW (405,
473, 532, 589, and 635 nm). The emission filters available, with widths in the 20-nm range, are 475, 531, 607,
624, and 670 nm. The excitation laser beam is directed through a set of mirrors toward a cylindrical lens (f =
50 mm), which together creates a light sheet of approximately t2 mm thickness.
In LSFM microscopy, the sample is illuminated with a thin light sheet, meaning that only one plane of the
sample is illuminated at each time point, in such a way that only the fluorescence emitted from that indi-
vidual plane is detected (Santi, 2011; Power and Huisken, 2017; Huisken et al., 2004). The plane of the spec-
imen exposed to the light can be selected by moving the sample until all required planes have been illu-
minated and detected. Therefore, a high-resolution 3D image can be constructed by scanning the whole
sample, plane by plane. The working principle of light sheet illumination is illustrated (Figure 1A).
LSFM offers benefits over world-wide used confocal microscopy, which, although is one of the most pop-
ular and accessible 3D imaging techniques, for the time being, has important limitations. Under the
confocal microscope, the fluorescence signal from non-focal planes is filtered out, but the whole sample
remains illuminated during acquisition, producing photobleaching at a rapid rate. The limitations of photo-
bleaching and out-of-focus fluorescence are avoided with LSFM, in which only one plane of the specimen is
selectively illuminated at each time point, whereas the rest of the sample is kept in the dark. Hence, fluo-
rophores are not illuminated for long periods, and there is no need to filter out-of-focus fluorescence since
only the focal plane produces a signal (Huisken and Stainier, 2009).
TRANSLATIONAL APPLICATIONS OF TISSUE CLEARING AND 3D IMAGING
Recent reports describe the use of different tissue clearing methods for several biological tissues and or-
gans. As discussed above, the method of choice would depend on the transparency of the organ, type of
fluorescence, the importance of tissue shrinkage, and clearing time. Here, we summarize tissue-clearing
strategies. Note that most of the information available for the tissues was obtained from mouse models
and that data for human tissues are still scarce. Different CUBIC cleared mouse organs are shown in
Figure 3.
Heart
A recent study compared tissue clearing reagents and protocols based on aqueous solvents to clear em-
bryonic and fetal hearts (Kolesová et al., 2016). CLARITY, SCALE, CUBIC, and dibenzylether (DBE) were
compared in terms of transparency and organ size. The authors concluded that the CUBIC method was
the best suited to clear the embryonic heart. Furthermore, CUBIC preserved endogenous protein fluores-
cence well, as confirmed by the detection of the heart GFP signal in a transgenic mouse model (Kolesová
et al., 2016). The CUBIC method can also be used to improve confocal imaging of relatively thick mouse
heart sections, as it enhances antibody penetration and light detection (Nehrhoff et al., 2016). The whole
mouse heart can be cleared with CUBIC allowing 3D vasculature image (Nehrhoff et al., 2017) (Figure 4). AiScience 21, 101432, August 21, 2020 15
Figure 3. Mouse Tissues Cleared with the CUBIC Protocol
Mice were perfused with 4% PFA and organs were extracted. The CUBIC clearing protocol was adapted to each tissue by




Reviewcombination of CUBIC and CLARITY, named SUT (Scheme Update on tissue Transparency), has been used
to evaluate spatial distribution and phenotype of fibroblasts in mice left ventricles in a post-myocardial
infarction (Wang et al., 2018). Additionally, a modified CLARITY method that skips the electrophoretic
step named SCM (Simplified CLARITY method) has been applied to mouse heart to study proteins distri-
bution (Sung et al., 2016).Skeletal Muscle
Skeletal muscle has been cleared with a mixture of reagents N, N, N0, N0-Tetrakis(2-hydroxypropyl), ethyl-
enediamine, urea, and RIMS, which are compatible with LacZ staining and fluorescent reporters (Verma
et al., 2016). Both confocal microscopy and two-photon microscopy have been used to image the cremas-
ter, diaphragm, digitorum longus, and soleus muscles (Verma et al., 2016). Skeletal muscle is a complex
tissue that hosts a variety of cell types, including myocyte syncytia, satellite cells, fibroblasts, and16 iScience 21, 101432, August 21, 2020
Figure 4. Mouse Hearts Cleared with CUBIC and Vasculature 3D Image
(A and B) Mice were perfused with PFA 4%, and the hearts were removed. The CUBIC clearing protocol was applied in (B);
(A) heart without clearing. Length of background squares: 3.85 mm.
(C) CUBIC cleared heart inside the cuvette.
(D and E) SPIM images of mouse heart vasculature. Mice were perfused with PFA 4% and Lectin-649Alexa, and the hearts
were removed and cleared with CUBIC protocol. 3D imaging of the heart was acquired with SPIM microscopy using 635
nm excitation laser, and 670 nm emission filter. Stripes artifact was removed with VSNR Fiji plugin, and 3D image





Reviewendothelial cells. The combination of clearing reagents and advanced imaging makes it possible to study
the connection between various cell populations during development, regeneration, fibrosis, atrophy, and
other physiological and pathological processes. Tissue clearing also enables the observation of changes in
myofiber organization and vasculature distribution in response to various insults. A report comparing
agents used to clear skeletal muscle found that 3DISCO had better clearing properties while preserving
the endogenous GFP signal (in transgenic animals) and immunofluorescence from labeled secondary an-
tibodies. In contrast, ClearT, ScaleA2, and CLARITY showed limitations with GFP and/or immunostaining
(Decroix et al., 2015). CUBIC has been used for muscle clearing in a mouse model of Duchenne muscular
dystrophy (Bozycki et al., 2018). Very recently, a new hydrogel-based tissue clearing method, MYOCLEAR,
has been described for the labeling and detection of all neuromuscular junctions and diaphragmmuscles in
mice to overcome the incompatibility of CLARITY with a-bungarotoxin, which is one of the main Ach-recep-
tor markers (Williams et al., 2019). Lastly, a very recent comparative study of different tissue clearing
methods 3DISCO, FDISCO, FRUIT, SeeDB, ScaleS, and CUBIC has been reported for the study of neuro-
muscular junctions in skeletal muscle (Yin et al., 2019). Clinically, the knowledge of the distributions of the
specific structures in themusclesmight be used by surgeons to avoid or reduce injuries to peripheral nerves
(Yin et al., 2019).Brain and Neural Tissue
This typeof tissue is themostwidely studied using tissue clearingmethods (Kimet al., 2018;Wanet al., 2018).




Reviewstep to remove the myelin sheets that enclose neuronal axons (Susaki et al., 2020), as their high lipidic con-
tent causes a large amount of scattering. An approach combining CLARITY with double photonmicroscopy
enabled visualization of gray matter in the intact brain (Chang et al., 2017). CLARITY has also been adapted
for visualization of astroglia inmice (Miller andRothstein, 2016). CUBICwasproposedas a newbrain clearing
method that obviates electrophoresis, in contrast to CLARITY (Susaki et al., 2014). CUBIC’s clearing capa-
bility of neural tissue has been quantitatively proved by means of a small-angle X-ray scattering analysis
(SAXS), which showed that CUBIC reagent 1 is capable of effectively removing the myelin sheet and, there-
fore, reducing scattering (Susaki et al., 2020). Chicken embryo brains have been successfully cleared with an
optimized CUBIC method (Gómez-Gaviro et al., 2017). Mouse brains have been rendered transparent with
an alternative CUBIC protocol named CUBIC 1, which uses CUBIC-L and CUBIC-P for the delipidation and
discoloration step. The discoloration is achieved by the competitive binding of 1-methylimidazole to heme
groups thanks to its structural similarity to histidine in globin. CUBIC 1 also uses CUBIC-R or a cheaper
version named CUBIC-RA for RI matching (Tainaka et al., 2018). When using neutral pH solutions, CUBIC1
was able to better preserve tissue volume and microstructure (Tainaka et al., 2018). These CUBIC methods
mainly aim at improving the sample’s transparency. However, a novel CUBIC pipeline that focuses on immu-
nostaining efficiency has been recently developed, named CUBIC-HistoVIsion. The authors demonstrated
the electrolyte-hydrogel behavior of fixed, delipidated tissues, what supports the application of the Lorentz-
Lorenz equation (which was stated in 1880 for polymers) to tissues, as mentioned in the introduction (Ueda
et al., 2020). They used this resemblance to optimize electrostatic interactions between the dye or immuno-
label and the gel, and improve their penetration by regulating pH, salt concentration, temperature, and
other environmental and chemical conditions (Susaki et al., 2020).
High-resolution whole-mouse brain atlas has been developed by using an alternatively modified CUBIC
protocol, named CUBIC-X. This method uses non-hydrogel-mediated expansion microscopy, by means
of imidazole/antipyrine aqueous cocktails, which largely preserve tissue fluorescence and structure (Mur-
akami et al., 2018). PACT has also been adapted for expansion microscopy (ePACT) for Brainbow visuali-
zation by an increase in the concentration of SDS used in the protocol (Treweek et al., 2015). Magnified
analysis of proteome (MAP) is an alternative expansion microscopy clearing protocol that has been used
for super-resolution mouse brain imaging (Mano and Albanese, 2018).
In order to improve the clearing efficiency of neonatal brains, ReagentF was developed as a modification of
ClearT by the addition of Triethanolamine (Poola et al., 2019). Alternatively, fetal brain tissue can be cleared
by applying 3DISCO in whole embryos (Table 1). This method is quite versatile and can also be used for the
study of other organs (Mano and Albanese, 2018). It is particularly advantageous for large ones since the
volume shrinkage produced by 3DISCO can make them fit into the small working distances of high-magni-
fication objectives. Ultimate DISCO (uDISCO) was recently reported to clear the whole mouse body (Pan
et al., 2016), including calcified bones with no need for a previous decalcification treatment. uDISCO in-
creases the half-life of endogenous fluorescent proteins, reduces clearing time compared with 3DISCO,
and uses tert-butanol, which is more stable than 3DISCO’s THF. However, it is a more complex protocol,
not compatible with tdTomato and increases background fluorescence. A modification of the 3DISCO
method, FDISCO (DISCO with superior Fluorescence preservation), has been developed very recently to
visualize neurons in the whole brain, to overcome the difficulty of uDISCO to clear myelin-rich tissues (Qi
et al., 2019). FDISCO showed better fluorescence conservation, required shorter clearing times, and was
compatible with tdTomato. GFP fluorescence preservation has been described modifying the protocol
uDisco by addition of alkaline triethylamine for high-quality visualization of neuronal structures and has
been called uDISCO (alkaline pH-based uDISCO). This protocol adjusts the pH value of uDISCO to the
optimal value for GFP stability to increase endogenous fluorescence and reduce background noise (Li
et al., 2018). An alternative modification of 3DISCO, sDISCO (stabilized DISCO), also provides a great
GFP fluorescence preservation in mouse brain by adjusting pH to an alkaline value and by using antifading
propyl gallate, which prevents fluorophore quenching by reducing decomposition of DBE and BABB into
peroxides and aldehydes. Additionally, iDISCO (immunolabeling enabled 3DISCO) has been used in
mouse brain to study degeneration of neurons in sensory ganglia. In order to reduce iDISCO-induced tis-
sue shrinking, iDISCO + has been developed by substituting THF by a combination of methanol and di-
chloromethane with no loss of clearing efficiency (Renier et al., 2016).
ACT-PRESTO (active CLARITY technique-pressure-related efficient and stable transfer of macromolecules




Reviewfor larger animals (Lee et al., 2016), thanks to the use of a highly porous hydrogel that allows better removal
of lipids and more rapid diffusion of macromolecules, compared with CLARITY. In order to better preserve
tissue architecture and fluorescence, an alternative hydrogel-based method named stabilization under
harsh conditions via intramolecular epoxide linkages to prevent degradation (SHIELD) has been used to
evaluate the synaptic architecture of virally labeled murine neurons at single–cell resolution (Park et al.,
2018). Additionally, in order to decrease CLARITY’s clearing times and protein loss and increase the signal
to noise ratio, Fast free of acrylamide clearing tissue (FACT) was developed by adjusting pH, temperature,
and SDS concentration (Xu et al., 2017).
ScaleSQ method has been optimized for brain thick sections. The modified protocol was named IsoSca-
leSQ and uses NaCl to reduce sample swelling and avoid tissue structure distortion (Sato et al., 2019),
similarly to CUBIC1A (Susaki and Ueda, 2016). BABB has been adapted for adult mouse brain by addition
of 1-propanol and maintenance of an alkaline media and has been renamed as FluoClearBABB (Schwarz
et al., 2015). PACT has been used to clear the whole rat brain by perfusion into the CSF circuitry (PARS-
CSF) (Yang et al., 2014a). SeeDB has been modified by combining fructose and urea to obtain an RI match-
ing solution of low viscosity appropriate for large organ clearing by intravital perfusion (Hou et al., 2015).
This protocol, named FRUIT, was capable of clearing a whole rabbit brain while retaining the advantages
of SeeDB (Hou et al., 2015). SeeDB2 has been introduced to achieve super resolution imaging of mouse
brain (Ke et al., 2016) by reducing spherical aberrations caused by RI mismatch. Additionally, in order to
provide rapid clearing with FP preservation while maintainingmembrane integrity, a novel clearingmethod
named UbasM (Urea-Based Amino Sugar Mixture) has been developed to visualize mouse brains (Chen
et al., 2018) and brains diseased from Alzheimer’s disease (Chen et al., 2017; Liu et al., 2018), by reducing
the amount of delipidation by minimizing the detergent concentration. MXDA-based Aqueous Clearing
System (MACS) is a clearing method that has been very recently developed, and that also reduces delipi-
dation, allowing, therefore, lipid staining with Dil labeling or other markers, and that, nevertheless, main-
tains a high clearing performance. It uses m-xylylenediamine (MXDA), which is a water-miscible liquid with a
high refractive Index that induces hyperhydration in a similar way to urea (Zhu et al., 2020).
Combinations of more than one clearing protocol with clearing reagents have also been tested in neural
tissues. For example, Passive CLARITY has been combined with TDE to adjust the refraction index and
thus clear the mouse central nervous system (Roberts et al., 2016). The reason for choosing TDE is its
low cost and adjustable RI, which can reach very high values despite its low viscosity. This may be due to
its polarizable sulfur atom (see Table 2). Additionally, iDISCO+ has been combined with Adipo-Clear
(see section Adipose Tissue) to improve the clearing of the whole rat brain by further optimization of the
delipidation step (Branch et al., 2019).Skin and Lymph Nodes
Skin can be cleared using agents such as sucrose, fructose, PEG-400 (Zaytsev et al., 2020), PEG-300, salicylic
acid (Zhao et al., 2016), glycerol (Zhong et al., 2010), or glucose solutions. These agents are commonly
known as SOCAs (skin optical clearing agents) and generally adjust skin refractive indexes and induce pack-
aging of scatterers such as collagen fibers (Tuchina et al., 2019) by dehydration-driven reduction of skin
thickness (Wen et al., 2010). Several penetration enhancers are widely used to facilitate their diffusion
and improve their clearing power; they can be classified into chemical penetration enhancers such as pro-
pylene glycol, DMSO (Zaytsev et al., 2020), ethanol (Zaytsev et al., 2020), azone (Zhao et al., 2016), dimethyl
sulfoxide (Genina et al., 2020), oleic acid (Zaytsev et al., 2020), and thiazone (Zaytsev et al., 2020) (the last
four ones achieve penetration enhancement by dissolving Stratum Corneum lipids) (Zaytsev et al., 2020),
and physical penetration enhancers, such as ultrasounds (sonophoresis) (Genina et al., 2020), microneedles
(Yoon et al., 2010), lasers (FLMA, fractional laser microablation) (Genina et al., 2020a), pneumatic pressure
(Damestani et al., 2014), heat (Damestani et al., 2014), or abrasive instruments (microdermabrasion) (Genina
et al., 2020). Different combinations of penetration enhancers have been applied to improve the efficacy of
several clearing agents. For instance, PEG-400 has been applied in combination with oleic acid and sono-
phoresis, improving optical clearing (Zaytsev et al., 2020). Besides, it has been shown that combined appli-
cation of microneedles and sonophoresis can enhance diffusion rate of 70% glycerol up to 2.3-fold
compared with microneedling alone (Yoon et al., 2010) and that FLMA in combination with sonophoresis
highly increases clearing speed of PEG-300 (Genina et al., 2020a). Additionally, combination of skin clean-
ing, microdermabrasion, sonophoresis, and glycerol application allowed improved signal detection in




Reviewmicroneedling, vacuum pre-treatment, and application of positive pressure increased porcine skin trans-
parency up to 25% (Damestani et al., 2014).
Skin clearing was found to be useful for the study of the vascular bed, blood flow dynamics, and the
response of vessels to vasoactive agents (Guo et al., 2016; Bashkatov et al., 2018). This ability to image
live blood flow has fostered the development of in vivo flow cytometry in vessels of themouse ear (Markovic
et al., 2013) and has allowed improved detection of circulating tumoral cells in subdermal blood vessels
(Menyaev et al., 2013).
A mouse whole body, including the skin, has been successfully cleared and imaged using vDISCO owing to
the nanobody-fluorescence boosting of the tissues (Cai et al., 2019). This recently developed technique
uses the uDISCO protocol for the clearing step and then performs fluorescence enhancement of GFP by
diffusion of nanobodies that carry bright synthetic fluorophores. Nanobodies must have a low molecular
weight and recognize fluorescent protein’s epitopes, so the variable domain of heavy chain antibodies
is used.
Lymph nodes have been cleared with 75% glycerol and Focus clear (Song et al., 2015), both of which
make it possible to visualize complex cellular structures and vascular and lymphatic networks and to
identify metastasizing melanoma cells deep inside the lymph node cortex. Clearing agents can also
be combined with LSFM to study the interaction between T cells and dendritic cells in the lymph
node in 3D (Abe et al., 2016; Ozga and Moalli, 2016). Murine lymph nodes have been reported to be
cleared with Ce3D too, which has been further applied to many other tissues, providing excellent results
regarding tissue transparency, fluorescence and structure preservation, clearing time, and immunostain-
ing (Li et al., 2019) (see Table 1).Mammary Gland
Although uncleared mammary gland tissue can provide information about structures near the surface, tis-
sue clearing offers a considerable advantage in the study of mammary gland development. Several tissue
clearing techniques have been proposed to clear the mouse mammary gland. Lloyd-Lewis et al. compared
PACT-RC, PACT-RIMS, 3DISCO, CUBIC, and SeeDB and concluded that See-DB and CUBIC rendered bet-
ter results in terms of transparency. Thesemethods have been used for the identification of the contribution
of different cell clones in the development of this tissue. They also allow healthy and tumor tissue in the
gland to be compared and mammary cells to be phenotyped within the tissue (Lloyd-Lewis et al., 2016).
Additionally, ScaleSQ has been used to clear breast cancer spheroids and enhance FUCCI fluorescence
in deeper regions (Costa et al., 2019).Kidney
Kidney biopsies have been cleared using the BABB tissue clearing reagent, which enables visualization of
changes in glomerular capsule cells that had not been observed in thin tissue sections (Olson et al., 2016).
This particular study showed how clearing methods could improve histological analysis by providing supe-
rior accuracy. The 3D approach enabled visualization of normal and damaged glomerular capsules and re-
vealed changes in the distribution and morphology of parietal epithelial cells. Recently, comparative
studies have been carried out using several reagents and protocols, including Scale and ECI, CLARITY, CU-
BIC1, and uDISCO, to study crescentic diseases that may include podocyte depletion (Puelles et al., 2019;
Masselink et al., 2019). Related to pathologies in the kidney, potassium-mediated tubule remodeling has
also been revealed by optical clearing (Saritas et al., 2018) and ethanol-ECi (ethyl-cinnamate) cleared kid-
neys have enabled the study of renal nephrosis. ECi is a harmless food additive that renders RI matching
and pH adjustment for fluorescent protein stability (Klingberg et al., 2017).Liver
The liver has been cleared with ClearT2, SeeDB, and CUBIC to determine the fate of the DNA vectors
used for gene therapy (Fumoto et al., 2016). The ability of CUBIC to reveal the 3D distribution of the
transgene was clearly superior, enabling light penetration of 1.5 mm. Nanoparticles in cells or in tissue
are better visualized with passive clearing tissue protocols than with electrophoretic methods. Hepato-
biliary clearance of nanoparticles was possible with CUBIC but not with electrophoresis (Sindhwani et al.,





3D imaging of the lungs is particularly useful, as the reconstruction of the whole anatomy of the organ is
challenging from small individual images. However, lung tissue has been cleared in very few studies. Benzyl
alcohol and benzyl benzoate have been used to clear lung tissue and to study lung innervation (Scott et al.,
2014). Lung infection in mice has been studied with CLARITY and PACT, which made it possible to detect
Mycobacterium tuberculosis granulomas expressing the tomato fluorescent protein as deep as 1 mm into
the tissue (Cronan et al., 2015). Fibrillary collagen in whole lung fibrosis can be visualized with BABB (Ochoa
et al., 2018). The entire accessory lobe of a fibrotic rat lung has been cleared with CRISTAL (Curing Resin-
Infiltrated Sample for Transparent Analysis with Light) and imaged with scanning laser optical tomography
with sub-alveolar resolution. CRISTAL encapsulates the specimen in a transparent resin that suppresses
sample movement and allows correlative imaging (Kellner et al., 2016).Intestine, Ovary, and Eye
Murine colon has been cleared for 3D imaging using vertically scanned LSFM (Dong et al., 2014). Image
clearing and LSFM microscopy have been applied to both human and mouse intestine samples (Brede
et al., 2012). The identification of structural alterations in a murine inflammatory bowel disease model
was possible on 3D-reconstructed images of the colon (Arranz et al., 2013). A TDE-based clearing protocol,
the ilLUmination of Cleared organs to IDentify target molecules method (LUCID), has allowed 3D imaging
of gastrointestinal porcine mucosa and may be applicable to human tissues (Mizutani et al., 2018). Ovarian
tissue and murine ovarian follicles have been cleared with CUBIC in EGFP transgenic mice (Kagami et al.,
2018). In the study of the eye, an intact mouse eye has been cleared with a new protocol called EyeCi,
bleaching the melanin with hydrogen peroxide and using solvent-based clearing, which enables ocular
and retinal vascular and neovascularization (Henning et al., 2019). CUBIC has also been combined with
hydrogen peroxide to clear the mouse eye. Cochlea and organo de corti have been cleared using CUBIC,
disco, and CLARITY (Urata et al., 2019).Hard Tissues
Hard tissues like bones and teeth have been cleared and imaged with a new method called PEGASOS
(polyethylene glycol [PEG]-associated solvent system), which uses PEG to protect endogenous fluores-
cence (Jing et al., 2018). Femur, knee joint, teeth, and mandible have been reconstructed in a 3D manner
when these tissues were cleared with this method. PEGASOS has also been shown to clear the intact mouse
brain imaging individual neurons and dorsal root ganglions directly through vertebrae. vDISCO and
CLARITY have been reported to clear hard tissues as well (Jing et al., 2018). Bones have also been cleared
with Ce3Dwithout prior decalcification (Li et al., 2017). CUBIC2 is a modified CUBIC1 protocol that includes
CUBIC-B for the decalcification step and has been reported to efficiently clear mouse limbs (Tainaka et al.,
2018). PACT-deCAL has been used to clear hard tissues by performing a previous decalcification step in
EDTA (Ariel, 2017). Similarly, iDISCO+ has been used to clear rat temporal bone by previously using
EDTA and 5% gelatin (Perin et al., 2019). Bone CLARITY has been applied tomice tibia, femur, and vertebral
column to view Sox9-tdTomato+ fluorescent osteoprogenitor cells (Greenbaum et al., 2017). However, and
contrary to PEGASOS, it is not able to clear soft tissues (Jing et al., 2018). Additionally, SeeDB2 has been
successfully applied to mouse nasal bone (Ke et al., 2016).Tumor Tissue
In the field of cancer research, tissue clearing has been used to study tumor development andmorphology.
Several tissue clearing protocols have been used to visualize tumor vasculature and tumor models (Feuch-
tinger et al., 2016).
Clearing of melanoma in in vivo animal models makes it possible to visualize tumormicrovasculature. This is
a particularly challenging tissue since pigmentation limits light penetrance. The use of clearing agents on
superficial layers of the skin improved melanoma imaging in vivo using optical coherent tomography,
together with white-light diffuse reflectance spectroscopy, which may have applications for the diagnosis
of melanoma (Pires et al., 2016). This particular application is feasible because the skin is an external organ
and allows in vivo clearing and imaging.
Lung carcinoma has been cleared with the CUBIC protocol combined with intravenous lectin injection,
post-labeling antibody-based techniques, and fluorescence in situ hybridization (FISH). These techniquesiScience 21, 101432, August 21, 2020 21
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Reviewwere used to assess tumor volume and spatial distribution of macrophage infiltration at the cellular level in
the whole lung (Cuccarese et al., 2017). An alternative CUBIC protocol named CUBIC-cancer has been
applied to evaluate metastasis evolution by analyzing different-stage mouse tumors. Similarly to CUBIC
1 it uses CUBIC-L as the delipidating solution and CUBIC-R for the RI matching step (Kubota et al., 2017).
Prostate specimens and prostate cancer samples have been analyzed with tissue clearing techniques com-
bined with confocal microscopy. Clearing the tissue with BABB increases the depth of penetration to
800 mm, as compared with the 70 mm achieved in uncleared tissue (van Royen et al., 2016).
Pancreatic intraepithelial neoplasms have been analyzed with clearing methods in a duct lesion model. By
using ‘‘commercial clearing solutions,’’ such as different types of CUBIC reagents provided by TCL Amer-
ica, or Focus Clear and DeepClear provided by CelExplorer, it was possible to unveil distinct growth pat-
terns and the relationship of the tumor cells with the surrounding vessels and microenvironment (Lin et al.,
2016). Tissue clearing has also been used for the study of pancreatic islet innervation by neural cells in non-
tumoral tissue, revealing neurovascular remodeling (Lin et al., 2016).
Scale, 3Disco, iDisco, uDISCO, SeeDB, and CLARITY have been used for the 3D visualization of gliomas,
brain vasculature, and tumor microenvironment, enabling the identification of glioblastoma networks (La-
gerweij et al., 2017). UbasM has been applied to murine lung to detect metastases of breast cancer (Chen
et al., 2017).Adipose Tissue
Optically clearing adipose tissue presents a great challenge owing to the large concentration of lipids that
it contains, which are mainly responsible for light scattering. To overcome this issue, a modified iDISCO+
protocol named Adipo-Clear was recently published to remove lipids from mouse adipose tissue without
altering its structure to study beige fat biogenesis (Chi et al., 2018).




ReviewHuman Tissues and Diagnostics
Very few studies have analyzed human tissue using clearing protocols, which havemainly focused on biopsy
specimens and accessible tissues such as skin (Wang et al., 2012). This growing field has now expanded to
in vivo tissue clearing approaches in dermatology. The use of topical SOCAs (Table 1) on human skin opens
a ‘‘window’’ that enables visualization of the dermal vasculature and deeper tissues (Shi et al., 2017). This
approach seems promising for the diagnosis of skin tumors and peripheral vascular diseases (Pires et al.,
2016).
The human eye has been cleared using SeeDB, enabling the visualization of choroid and retina (Hohberger
et al., 2017). This opens up the possibility for pathologists to study intraocular diseases, such as retinal tu-
mors, which would now be possible in non-dissected eyes.
Tissue clearing has allowed the study of large and small vessels in different human tissues. The aorta has
been cleared with BABB in humans and allows discriminating between a healthy abdominal aorta and
an aortic aneurysm (Niestrawska et al., 2016). The authors identified severe structural deficiencies in aortic
aneurysms, particularly those affecting the collagen fibers surrounding the aorta. Human placental tissue
and its vasculature have been imaged in 3D following tissue clearing with CLARITY and X-CLARITY, the
latter being able to clear the tissue in half the time (Carrillo et al., 2018). Human gingiva has been cleared
with BABB, and iDISCO and light-sheet microscopy have enabled the acquisition of 3D images of capil-
laries in stromal papillae invading stratified epithelium. Human gingival morphology and vascular struc-
tures using patient waste material can be analyzed using this technology (Azaripour et al., 2018).
Human myocardial tissue has been cleared with Free-of-Acrylamide SDS-based Tissue Clearing (FAST-
Clear), which combines iDISCO with a non-hydrogel version of CLARITY (Perbellini et al., 2017). The acqui-
sition of quality images of this tissue is challenging because of its high cellular density. The clearingmethod
used in this work enabled the acquisition of a 3D image of the fibrotic area of an infarcted region and its
associated vascular network. This tool allows the accurate analysis of fibrotic tissue distribution within
the heart, improving the sensitivity and objectivity of diagnosis and treatments. The human heart has
also been cleared with CUBIC3, which is a recently optimized CUBIC protocol designed to obtain a rapid
and aggressive clearing. It uses CUBIC-HL for delipidation and also discoloration, and CUBIC-R for the RI
matching step. It preserves endogenous proteins better but can hinder fluorescence in some cases (Tai-
naka et al., 2018).
Tissue clearing protocols have also been applied to the human trachea, unveiling tracheal innervation at all
depths. Using this approach, human tracheal tissue compartments can be easily identified and intrinsic
airway ganglia can be quantified (Scott et al., 2014). The human pancreas has also been cleared to visualize
the neuroinsular network (Butterworth et al., 2018).
Finally, the human brain has been cleared with CLARITY, enabling the direct comparison between MRI-
based and microscopy-based 3D histology on aged postmortem brain samples (Morawski et al., 2018).
An alternative to CLARITY has been developed to withstand elution and to allow multiplexing imaging
of human brain samples by several labeling and delabeling antibody steps. This protocol, named SWITCH
(System-Wide control of Interaction Time and kinetics of Chemicals), uses acidic (SWITCH-off) and alkaline
(SWITCH-on) solutions to induce homogeneous gel formation in the sample and increase antibody pene-
tration. The resulting GA-BSA gel renders high mechanical, chemical, and thermal stability of the sample,
allowing high temperature (and therefore fast) clearing with SDS and reducing agents (Murray et al., 2015).
Additionally, both fresh and archival human brains have been cleared with OPTIClear (Optical Properties-
adjusting Tissue-Clearing agent), which is an RI matching solution that uses TDE for the hydrophilic brain
compartments and iohexol for the hydrophobic ones (Lai et al., 2018). It renders great transparency without
a prior delipidation step. It also preserves tissue integrity, although fluorescence is slightly hindered. It has
been used with confocal microscopy, but its utility for LSFM has not been studied yet (Lai et al., 2018). The
CUBIC protocol has also been modified to clear human brain. By using CUBIC-L as the delipidating and
decolorating reagent, and CUBIC-R for the RI matching step, the so-called CUBIC4 is a rapid, FP-compat-
ible and endogenous protein preserving protocol that has a higher clearing performance than conven-
tional CUBIC. A DISCO-based clearing method that focuses on fluorescent labeling has been developed
to analyze human cortex cytoarchitecture. This method, namedMultiscale Architectonic Staining of HumaniScience 21, 101432, August 21, 2020 23
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ReviewCortex (MASH), makes use of small organic fluorescent dyes and a set of adjustable refractive index solu-
tions specially adapted for large human samples (Hildebrand et al., 2018).
Human cerebral organoids have been cleared with 2ECi (second-generation ethyl cinnamate-based
clearing method), which was developed to overcome long clearing times of aqueous-based clearing
methods and fluorescence quenching of organic solvents (Masselink et al., 2019).
A summary of tissue clearing methods and reagents for human tissues is represented in Figure 6.OPTICAL CLEARING AND 2D AND 3D IMAGING AS A PATHOLOGY DIAGNOSIS TOOL
Despite the difficulties to clear human tissue, LSM has proved to be an efficient and reliable histopatholog-
ical tool for biopsy analysis. By performing optical clearing and by means of different types of light sheet
microscopy such as OT-LSM, biopsies obtained from kidney, breast, and prostate have been successfully
analyzed with a similar subcellular resolution to that obtained by standard histological imaging such as
H&E staining. As sample sectioning is not required, optical clearing and 3D imaging can be used to obtain
more reliable structural and functional information from the biopsy and, therefore, a more accurate diag-
nosis. This may be very useful for efficient tumor margin assessment (Poola et al., 2019). Optical clearing has
also been presented as a novel 3D histopathology technique for pancreatic lesions diagnosis (Hong et al.,
2019).
Optical clearing has shown to increase the efficiency of medical diagnosis by additional imaging systems,
such as optical coherence tomography, which allowed subepidermal melanoma identification in vivo (Gen-
ina et al., 2015), and photoacoustics, which was used for non-invasive detection of glucose content of blood
vessels and tissues in vivo (Genina et al., 2015). It has also allowed optimization of tissue elasticity analysis
by High-Resolution micro-Brillouin spectroscopy (HRmBS) (Rioboo et al., 2019). This novel type of spec-
trometer-based imaging technique is used to detect intrinsic sound waves of the tissue, which are caused
by molecular thermodynamic movement or phonons. The amplitude and frequency of the waves, and
therefore their energy, depend on the elasticity of the tissue. When the sample is irradiated with a laser




Reviewfrequency; others encounter a retreating wave that increases their energy, and the rest of the photons
remain unaltered, so for isotropic materials, an output of three main symmetric frequency peaks is ob-
tained, known as the anti-Stokes, Rayleigh, and Stokes peaks. The shift between the peaks is directly
dependent on the elasticity constant of the tissue (Rioboo et al., 2019).
The laser beam is reflected by backscattering and directed into the Brillouin spectrometer. The basis of the
Fabry-Perot spectrometer is a pair of highly reflective mirrors between which the entering laser suffers
constructive or destructive interference with itself. The distance between the mirrors determines the fre-
quency that can escape to the detector. By regulating this distance by means of a piezoelectric device,
an almost analog spectroscopic analysis of the laser beam can be performed. Optical clearing of the tissue
has been proved to increase the SNR (sound to noise ratio) of the measured signal without modifying the
frequency shift, i.e., without altering its physical properties, therefore increasing signal quality and
reducing acquisition time (Rioboo et al., 2019).
This technique has promising perspectives for the diagnosis of cardiovascular diseases (Rioboo et al., 2019)
or for in vivo assessment of skin pathologies since an elasticity change is often a sign of disease. Brillouin
microscopy may also be used in clinical practice to detect keratoconus (Yun and Chernyak, 2018). Although
there are other currently available techniques such as the atomic force microscopy (AFM) that also provide
information regarding the mechanical behavior of the sample, HRmBS is non-invasive and does not require
mechanical devices to interact with the sample (Rioboo et al., 2019). However, AFM allows for the compu-
tation of Young’s elastic modulus, whereas HRmBS can only measure the longitudinal elasticity modulus,
which assumes no strain in other directions different from the probing one (Elsayad et al., 2016).
In the coming years, the application of optical clearing as an aid of tissue elasticity analysis or optical im-
aging for in vivo diagnosis of skin pathologies may become a reality. For instance, as mentioned in section
Skin and LymphNodes, optical clearing has already been applied in vivo tomouse ear (Guo et al., 2016) and
to rat skin (Mao et al., 2009). A 30% glycerol solution was used as a refractive index matcher of dermic
collagen without causing necrosis (Mao et al., 2009). Rat skin has also been cleared in vivowith 40% glucose
solutions (Tuchina et al., 2019) and with PEG-300 in combination with FLMA/sonophoresis, the latter
achieving maximal transparency in 90 min (Genina et al., 2020a).
Optical clearing has been applied in vivo to human skin too. Optical clearing with polypropylene glycol-
based polymers and polyethylene glycol-based pre-polymer mixture enhanced visibility of telangiectasias
to up to 500 mm (Khan et al., 2004). Glycerol has been applied to in vivo human skin with prior Stratum Cor-
neum removal (Fox et al., 2009), and 40% glucose solutions have been injected subcutaneously inducing
long term increased transparency of in vivo human dermis (Tuchin et al., 2001). Recently, a novel skin optical
clearing method named MOUSE (Microdermabrasion, Oleic acid, and UltraSound Effect) has been suc-
cessfully applied to human skin in vivo (Genina et al., 2020), further increasing light penetration depth to
800 mm. Additionally, and asmentioned in section Tumor Tissue, optical clearing agents have been applied
in vivo to human melanoma to image microvascular networks (Pires et al., 2016). However, in vivo optical
clearing is currently focused on the skin only, more specifically dermis, owing to its extension and optical
accessibility (Costantini et al., 2019). As an exception, the mouse skull has been optically cleared in vivo to
image brain microvasculature and neurons at a cortical level by means of two photon microscopy (Zhao
et al., 2018).
Still, in vivo optical clearing is very limited by the mandatory requirement of chemical and physical
biocompatibility with living tissues. Most of the currently available optical clearing methods are chemi-
cally aggressive, toxic, or irreversible, narrowing the available range to a few aqueous solutions (Costan-
tini et al., 2019).DISCUSSION AND FUTURE PERSPECTIVES
Originally described for brain tissue, clearing protocols have been extended to many other tissues. The
choice of clearing agent and protocol depends on the specimen, the developmental stage, the character-
istics of the tissue to be analyzed, and whether it will be applied in vivo or ex vivo. The nature and opacity of




ReviewTissue clearing makes possible to overcome some major limitations of (confocal) microscopy for the 3D
study of organ structure; however, the approach still faces technical challenges that need to be ad-
dressed in the future. To date, tissue clearing has been applied mainly to small animals, with few data
reported on human tissue. Human samples are difficult to perfuse, thus potentially generating technical
limitations. Furthermore, the large size of human samples is a challenge in the 3D analysis of human
tissue.
The development of more novel clearing protocols might minimize the problems of molecular dyes con-
jugated to antibodies fluorescence quenching, interruption of tissue integrity, endogenous protein fluores-
cence preservation, and deeper tissue light penetration, which remain challenging. More advanced imag-
ing devices, such as new-generation LSFM with higher image resolution, faster acquisition, and multiple
angle illumination, together with more sophisticated post-imaging analysis software, will enable more ac-
curate 3D analysis at cellular (and even subcellular) resolution.
The field of whole-organ imaging at subcellular resolution is moving forward at great speed, mainly due to
the advance of new and more efficient clearing protocols, combined with microscopy modalities in
biomedical research, clinical diagnosis, and patient follow-up.
CONCLUSIONS
Clearing protocols enable researchers to obtain more accurate optical 3D images of different human and
animal tissues. Microanatomy and tissue cytoarchitecture can be analyzed, preserving the tissue structure
and providing more accurate data with this emerging technology. The combination of animal models of
human diseases with clearing protocols and LSFM imaging enables 3D visualization of organ damage
and provide a more accurate basis for diagnosis and treatment.
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